Abstract

MIR137 has been identified as a candidate gene for schizophrenia from genome-wide association studies via association with an intronic single nucleotide polymorphism (SNP), rs1625579. The location of the SNP suggests one mechanism in which transcriptional or posttranscriptional regulation of miR-137 expression could underlie schizophrenia. We identified and validated a novel promoter of the MIR137 gene adjacent to miR-137 itself which can direct the expression of distinct mRNA isoforms encoding miR-137. Analysis of both endogenous gene expression and reporter gene assays determined that this internal promoter is regulated by repressor element-1 silencing transcription factor (REST), which has previously been associated with pathways linked to schizophrenia. Distinct isoforms of REST mediate differential expression at this locus, suggesting the relative levels of these isoforms are important for miR-137 expression profiles. The internal promoter contains a variable number tandem repeat (VNTR) domain adjacent to the pre-miR-137 sequence. The reporter gene activity directed by this promoter was modified by the genotype of the VNTR. Differential expression was also observed in response to cocaine, which is known to regulate the REST pathway in SH-SY5Y cells. Our data support the hypothesis that a “gene × environment” interaction could modify the level of miR-137 expression via this internal promoter and that the genotype of the VNTR could modulate transcriptional responses. We demonstrate that this promoter region is not in disequilibrium with rs1625579 and therefore would supply a distinct pathway to potentially alter miR-137 levels in response to environmental cues.

Highlights

  • Genome-wide association study (GWAS) for schizophrenia identified the intronic single nucleotide polymorphism (SNP) rs1625579 within the MIR137 gene to be strongly associated.[1]

  • Analysis of both endogenous gene expression and reporter gene assays determined that this internal promoter is regulated by repressor element-1 silencing transcription factor (REST), which has previously been associated with pathways linked to schizophrenia

  • chromatin immunoprecipitation (ChIP)-seq data from ENCODE34,35 identified only RNA Polymerase II and the transcription factor REST binding over the MIR137 variable number tandem repeat (VNTR)

Read more

Summary

Introduction

Genome-wide association study (GWAS) for schizophrenia identified the intronic single nucleotide polymorphism (SNP) rs1625579 within the MIR137 gene to be strongly associated.[1] The risk genotype for this variant is a strong predictor for earlier age-at-onset of psychosis and is associated with structural changes within the brain relative to carriers of the protective allele and healthy matched controls.[2] MIR137 encodes for the microRNA-137 (miR137), which functions in neurodevelopment, adult neurogenesis[3,4] and is a validated regulator of GWAS candidate genes for schizophrenia,[1,5,6] suggesting that impairments in the regulation and/or function of miR-137 may be a key mechanism in neuropsychiatric disease. Bioinformatic analysis of the MIR137 locus predicted an internal promoter adjacent to the miR-137 sequence (figure 1). REST predominantly functions as a transcriptional repressor of neuronal gene expression through binding the RE1 (repressor element-1) or NRSE (neuron restrictive silencing element).[19,20] Modulation of REST is associated with neurological dysfunction, including schizophrenia,[21] with genetic variants being implicated

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call